Skip to content
OpenCapital
Get started

Opus Genetics IRD Compensation and benefits

Compensation and benefits at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$29.4M-29.0%

Other financials

Income statement

See full
Revenue$2.2M-50.6%
Operating income-$14.4M-44.7%
Net income-$65.5M-700%
EPS (diluted)-$0.75-213%

Balance sheet

See full
Cash & equivalents$60.0M+43.5%
Total debt$1.2M—
Total equity-$45.8M-1,004%
Total assets$66.8M+38.7%

Cash flow

See full
Operating cash flow-$12.7M-41.5%

Valuation

See full
Market cap$307.14M+442%
Enterprise value$248.38M—
P/S25.6×+21.5×

Profitability

See full
Operating margin-359.1%-68.9pp
Net margin-892.4%-12,322pp

Returns & leverage

See full
Return on equity-449.4%-2,573pp
Debt / equity0.1×—
Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opus Genetics's compensation and benefits?
Opus Genetics (IRD) reported compensation and benefits of $1.46M in Q1 2026.
How has Opus Genetics's compensation and benefits changed year-over-year?
Opus Genetics's compensation and benefits increased by 60.4% year-over-year, from $913K to $1.46M.
What is the long-term trend for Opus Genetics's compensation and benefits?
Over 4 years (2021 to 2025), Opus Genetics's compensation and benefits has grown at a 15.4% compound annual growth rate (CAGR), from $1.91M to $3.4M.
What does compensation and benefits mean?
Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.